Mouse skeletal muscle adaptations to different durations of treadmill exercise after the cessation of FOLFOX chemotherapy
- PMID: 38028800
- PMCID: PMC10648895
- DOI: 10.3389/fphys.2023.1283674
Mouse skeletal muscle adaptations to different durations of treadmill exercise after the cessation of FOLFOX chemotherapy
Abstract
FOLFOX (5-fluorouracil, leucovorin, oxaliplatin) chemotherapy is a treatment for colorectal cancer that can induce persistent fatigue and metabolic dysfunction. Regular exercise after chemotherapy cessation is widely recommended for cancer patients and has been shown to improve fatigue resistance in mice. However, gaps remain in understanding whether the early systemic and skeletal muscle adaptations to regular exercise are altered by prior FOLFOX chemotherapy treatment. Furthermore, the effects of exercise duration on early metabolic and skeletal muscle transcriptional adaptations are not fully established. Purpose: Investigate the effects of prior FOLFOX chemotherapy treatment on the early adaptations to repeated short- or long-duration treadmill exercise, including the fasting regulation of circulating metabolic regulators, skeletal muscle COXIV activity and myokine/exerkine gene expression in male mice. Methods: Male C57BL6/J mice completed 4 cycles of FOLFOX or PBS and were allowed to recover for 4-weeks. Subsets of mice performed 14 sessions (6 d/wk, 18 m/min, 5% grade) of short- (10 min/d) or long-duration (55 min/d) treadmill exercise. Blood plasma and muscle tissues were collected 48-72 h after the last exercise bout for biochemical analyses. Results: Long-duration exercise increased fasting plasma osteocalcin, LIF, and IL-6 in healthy PBS mice, and these changes were ablated by prior FOLFOX treatment. Slow-oxidative soleus muscle COXIV activity increased in response to long-duration exercise in PBS mice, which was blocked by prior FOLFOX treatment. Fast-glycolytic plantaris muscle COXIV activity increased with short-duration exercise independent of FOLFOX administration. There was a main effect for long-duration exercise to increase fasting muscle IL-6 and COXIV mRNA expression independent of FOLFOX. FOLFOX administration reduced muscle IL-6, LIF, and BDNF mRNA expression irrespective of long-duration exercise. Interestingly, short-duration exercise suppressed the FOLXOX induction of muscle myostatin mRNA expression. Conclusion: FOLFOX attenuated early exercise adaptations related to fasting circulating osteocalcin, LIF, and IL-6. However, prior FOLFOX treatment did not alter the exercise adaptations of plantaris muscle COXIV activity and plasma adiponectin. An improved understanding of mechanisms underlying exercise adaptations after chemotherapy will provide the basis for successfully treating fatigue and metabolic dysfunction in cancer survivors.
Keywords: COXIV; IL-6; LIF; cancer survivors; exerkines; myokines; myostatin.
Copyright © 2023 Halle, Counts, Zhang, James, Puppa, Alway and Carson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g001.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g002.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g003.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g004.gif)
![FIGURE 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g005.gif)
![FIGURE 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g006.gif)
![FIGURE 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10648895/bin/fphys-14-1283674-g007.gif)
Similar articles
-
Recovery from FOLFOX chemotherapy-induced systemic and skeletal muscle metabolic dysfunction in mice.Am J Physiol Endocrinol Metab. 2023 Aug 1;325(2):E132-E151. doi: 10.1152/ajpendo.00096.2023. Epub 2023 Jun 28. Am J Physiol Endocrinol Metab. 2023. PMID: 37378624
-
Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression.Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188761. doi: 10.1016/j.bbcan.2022.188761. Epub 2022 Jul 16. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35850277 Review.
-
Short duration treadmill exercise improves physical function and skeletal muscle mitochondria protein expression after recovery from FOLFOX chemotherapy in male mice.FASEB J. 2022 Aug;36(8):e22437. doi: 10.1096/fj.202200460R. FASEB J. 2022. PMID: 35816153
-
A focused review of myokines as a potential contributor to muscle hypertrophy from resistance-based exercise.Eur J Appl Physiol. 2020 May;120(5):941-959. doi: 10.1007/s00421-020-04337-1. Epub 2020 Mar 6. Eur J Appl Physiol. 2020. PMID: 32144492 Review.
-
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4. Lancet Oncol. 2014. PMID: 25201358 Clinical Trial.
References
-
- Bland K. A., Neil-Sztramko S. E., Zadravec K., Medysky M. E., Kong J., Winters-Stone K. M., et al. (2021). Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate. BMC cancer 21 (1), 1–19. 10.1186/s12885-021-08701-y - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources